Member Info for SlowRoll

I hope you are correct!!!

"Term time" Sheffield Uni. I give up! Academia at its worst Do they have no idea of commercial expediency. No wonder the country is dying on its feet . The Chinese would be working on this 24/7 , probably are and will have one on the market before we launch.

Insider Intelligence estimates that there will be a staggering 26m monthly e-sports viewers in the USA this year. This is forecast to be over 31m in 2023. Part of the growth in North America is being attributed to endorsements like big celebrities (e.g. Michael Jordan) and to the success of Fortnite.

The industry is already seeing growing interest from venture capital and private equity firms, and Statista also estimates that global revenue from the industry will have topped $1.6bn in 2024.

We think the story has legs and a good way to tip a toe in the water is via an investment company that can take stakes in the faster growing opportunities in the market, many of which will be unlisted and hard to get into otherwise.

On GB News tonight featured for ten minutes Prof Marin Shaw of Exeter University and his 8 minute antibody test .. a blood test which is available in Pharmacies NOW. Time we got spinning, come on Prof Smythe put it out there. Let the people know. It'ss been coming two years too long.!!!

Been waiting four years for Blu since before the abortive RTO!

Glad my BLU are compensating for this dip!

Saw that on Google as well. Aberration? Or significant?

The price of bitcoin could surge to more than $500,000 as institutional investors begin to allocate to the relatively new cryptocurrency space, Ark Invest's Cathie Wood told CNBC in an interview on Thursday.

Wood explained that institutions are always in search of investments that are uncorrelated to traditional asset classes like stocks and bonds, and crypto fits that bill.

"I think institutions are moving in [to crypto] right now," Wood said, adding that they currently prefer the two largest cryptocurrencies, bitcoin and ether. As a whole, according to Wood, institutions barely have any exposure to the space.

"The reason institutions are moving in is to some extent this is a new asset class with correlations very different compared to other asset classes," Wood explained. A study conducted by Ark Invest found that the asset with the closest correlation to bitcoin is real estate.

That runs counter to the commonly held belief that cryptocurrencies are risk assets that move in tandem with broader moves in the stock market. For example, amid the Omicron-induced stock market sell-off last week, bitcoin entered a bear market, falling more than 20% from its recent high.

Hope BLU comes good for us Duke.

Not as bad as MySQUAR! Any one else a victim? Eric Schafer just stole our money. A really true fraudster who should be in Changi Jail with hard labour!!. The regulator won't help you, he is too much like Bailey at the Bank. Watch your own backs on aim

Switzerland currently has no national levy on capital gains but many cantons, which have wide-ranging autonomy on fiscal matters, charge holders of financial assets with a wealth tax.

Just to cheer us all up!
"THE UK is in talks to roll out an all-in-one test from the US that can detect Covid, flu and the common respiratory virus RSV to help alleviate winter pressures facing the NHS.

It would work in the same way as a Covid PCR test, with nasal swabs being sent off to a lab for analysis.

‘You get three green lights when all genes are detected. The software reports a red light if nothing is detected’
But instead of only looking for signs of coronavirus, the winter panel would simultaneously look for a variety of viruses known to be in circulation.

Thermo Fisher, an American company based in Massachusetts, which specialises in the manufacture and supply of scientific tools, tests and materials, has already made the kit and had it approved.”

Speed now is of the essence!

The smiling prof has in the past tweeted and caused great excitement, which has subsequently been tempered by bland company statements. Just cautious until we have good solid company announcements. The prof is not a shareholder and in it to enhance his professional reputation. Twitter is just gossip!

Well , we've been up at £1.30 earlier in the year on a massive spike from around 40p. Anything is possible!

These subscribers must be pretty ****ed! Glad I didn't participate people were falling over themselves to invest!!!. Should have followed Wall when he took out £3.7 Million and sold in February at £2.43! Rather dwarfs his recent purchase of 71,000 shares
"Offer for subscription conducted by PrimaryBid Limited of 3,399,433 new Ordinary Shares and subscription of 361,977 new Ordinary Shares to certain US investors, all at an Issue Price of 200 pence per share."

"Diagnosing diseases with a puff of breath
Soon, testing for disease could be as simple for patients as exhaling. New breath sensors can diagnose diseases by sampling the concentrations of the more than 800 compounds contained in human breath. For instance, elevated amounts of acetone in human breath indicate diabetes mellitus. The sensors look for changes in electrical resistance as breath compounds flow over a metal-oxide semiconductor. Algorithms then analyze the sensor data.

While this emerging technology needs refinements before it can become widespread, in a March 2020 study in Wuhan, China, sensors achieved a remarkable 95 percent accuracy in COVID-19 detection and 100% sensitivity in differentiating patients."

The group, formerly known as Hutchison China Meditech, also has a handful of new oncology drugs under development in the US and Europe. Earlier this year, the European Medicines Agency validated and accepted its marketing authorisation application for Hutchmed’s Surufatinib treatment for pancreatic tumours, though it could be argued that China presents the key commercial opportunity due to the size of its addressable market.

Management anticipates a significant increase in oncology and immunology sales over 2021, but the approvals process and R&D expenditure places a heavy burden on cashflows regardless of the strategic partnerships underway. Yet, the group exited its June half-year with negligible bank borrowings and net cash of $914m (£667m), enough to support further clinical progress this year and beyond. Speculative buy. MR

Was it an accidental release? Which country has benefited most? What was Faucci's role in it all?

Anyone know the ticker for the Paradigm VC fund?

In a 45-page report for clients, entitled Plugging into the Hydrogen Ecosystem, the New York-headquartered company estimates that the worldwide supply of electrolysers by 2030 “could sit somewhere in the 30-40GW range”. This compares to 54GW of announced projects and 94GW of what it calls “pledged” projects.
“The conclusion is that there is unlikely to be sufficient supply even for the proposed projects out to 2030 even in the lowest demand scenario,” the document states.
It also points out that the International Energy Agency expects to see 180GW of electrolysers in use by 2030 under its Announced Pledges Scenario, while its Net Zero Emissions by 2050 scenario requires a whopping 850GW.